Phytochemical properties of Ganoderma applanatum as potential agents in the application of nanotechnology in modern day medical practice

Asian Pacific Journal of Tropical Biomedicine

Volumn 2, Issue 2 SUPPL., 2012, Pages

  Manasseh, Akpera T ^a   Godwin, Jombo T A ^a   Emanghe, E Ubleni ^b   Borisde, Oguntayo O ^c  

^a BENUE STATE UNIVERSITY   (Nigeria)

^b UNIVERSITY OF CALABAR   (Nigeria)

^c Department of Haematology   (Nigeria)

Author keywords

African Trypanosomiasis; Ganoderma applanatum; Nanotechnology; Phytochemistry

Indexed keywords

ALKALOID; ANTHRAQUINONE DERIVATIVE; CARDIAC GLYCOSIDE; DISTILLED WATER; FLAVONOID; GANODERMA APPLANATUM EXTRACT; HOT WATER; PHYTOSTEROL; PLANT EXTRACT; SAPONIN; TANNIN DERIVATIVE; UNCLASSIFIED DRUG; WATER;

AFRICAN TRYPANOSOMIASIS; ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS SOLUTION; BLOOD SAMPLING; CHEMICAL COMPOSITION; CONTROLLED STUDY; DEATH; DRUG EFFICACY; DRUG SCREENING; GANODERMA APPLANATUM; GIEMSA STAIN; MEDICAL PRACTICE; NANOENGINEERING; NANOTECHNOLOGY; NONHUMAN; PARASITE IDENTIFICATION; PHYTOCHEMISTRY; PRIORITY JOURNAL; RAT; REVIEW;

GANODERMA; GANODERMA APPLANATUM; RATTUS; RATTUS NORVEGICUS; TRYPANOSOMA BRUCEI BRUCEI;

EID: 84865985171     PISSN: 22211691     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2221-1691(12)60277-9     Document Type: Article

References (47)

1. Cui D, Tian F, Coyer S, Wang J, Pan B, Gao F, He R, Zhang Y Effects of antisense-myc-conjugated single-walled carbon nanotubes on HL-60 cells. J NeurosciTechnol 2007, 7:1639-1641.
2. Pantarotto D, Partidos CD, Hoebeke J, Brown F, Kramer E, Briand JP, Muller S, Prato M, Bianco A Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses. Chemistry and Biology 2003, 10(10):961-966.
3. Bhaskar S, Tian F, Stoeger T, Kreyling W, De la Fuente JM, Grazu V, Borm P, Estrada G, Ntiziachristos V, Razansky D Multifunctional nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier perspectives on tracking and neuroimaging. Part Fibre Toxicol 2010, 7:e3. PMCID: PMC 2847536.
4. Gabor F "Characterization of Nanoparticles Intended for Drug Delivery" Sci Pharm 2011, 79(3):S701-S702. 10.3797/scipharm.br-11-01.
5. Saraiva J, Marotta-Oliveira SS, Cicillini SA, Eloy JO, Marchetti JM Nanocarriers for Nitric Oxide Delivery. J Drug Deliv 2011, 2011:936438. 10.1155/2011/936438.
6. Gandapu U, Chaitanya RK, Kishore G, Reddy RC, Kondapi AK Curcumin-Loaded Apotransferrin Nanoparticles Provide Efficient Cellular Uptake and EffectivelyInhibit HIV-1 Replication In Vitro. PLoSOne 2011, 6(8):e23388. 10.1371/journal.pone.0023388.
7. Gyenge EB, Darphin X, Wirth A, Pieles U, Walt H, Bredell M, Maake C Uptake and fate of surface modified silica nanoparticles in head and neck squamous cell carcinoma. J Nanobiotechnology 2011, 9:32. 10.1186/1477-3155-9-32.
8. Zhao W, Lu X, Yuan Y, Liu C, Yang B, Hong H, Wang G, Zeng F Effect of size and processing method on the cytotoxicity of realgar nanoparticles in cancer cell lines. Int J Nanomedicineyv 2011, 6:1569-1577. 10.2147/IJN.S21373.
9. Vazquez E, Corchero JL, Villaverde A Post-production protein stability: trouble beyond the cell factory. Microb Cell Fact 2011, 10:e60. 10.1186/1475-2859-10-60.
10. Jombo GTA, Damen JG, Amechi I, Etukudo NS, Dabit O Intestinal parasitosis among undernourished children of an urban settlement in West Africa: pattern and types. Asian J Pharmaceutical & Health Sci 2011, In Press.
11. Tran PA, Webster TJ Selenium nanoparticles inhibit Staphylococcus aureus growth. Int J Nanomedicine 2011, 6:1553-1558. 10.2147/IJN.S21729.
12. Fang Q, Kani K, Faca VM, Zhang W, Zhang Q, Jain A, Hanash S, Agus DB, McIntosh MW, Mallick P Impact of Protein Stability, Cellular Localization, and Abundance on Proteomic Detection of Tumor-Derived Proteins in Plasma. PLoS One 2011, 6(7):e23090. 10.1371/journal.pone.0023090.
13. Taylor E, Webster TJ Reducing infections through nanotechnology and nanoparticles. Int J Nanomedicine 2011, 6:1463-1473. 10.2147/IJN.S22021.
14. Hsu CK, Liao MH, Tai YT, Liu SH, Ou KL, Fang SW, Lee IJ, Chen RM Nanoparticles prepared from the water extract of Gusuibu (Drynariafortunei J. Sm.) protects osteoblasts against insults and promotes cell maturation. Int J Nanomedicine 2011, 6:1405-1413. 10.2147/IJN.S20473.
15. Vivero-Escoto JL, Huang YT Inorganic-Organic Hybrid Nanomaterials for Therapeutic and Diagnostic Imaging Applications. Int J Mol Sci 2011, 12(6):3888-3927. 10.3390/ijms12063888.
16. Wasser SP Current findings, future trends and unsolved problems in studies of medicinal mushrooms. Appl Microbiol Biotechnol 2011, 89(5):1323-1332.
17. Chai S, To KKW, Lin G Circumvention of multiply drug resistance of cancer cells by Chinese herbal medicines. Clin Med 2010, 5:e26. 10.1186/1749-8548-5-26.
18. Lindequist U, Niedermeyer THJ, Julich WD The pharmacological properties of mushrooms. Evidence Based Complement Alternat Med 2005, 2(3):285-299.
19. Cavallaro AS, Mahony D, Commins M, Mahony TJ, Mitter N Endotoxin-free purification for the isolation of Bovine Viral Diarrhoea Virus E2 protein from insoluble inclusion body aggregates. Microb Cell Fact 2011, 10:e57. 10.1186/1475-2859-10-57.
20. Ai J, Biazar E, Jafarpour M, Montazeri M, Majdi A, Aminifard S, Zafari M, Akbari HR, Rad HG Nanotoxicology and nanoparticle safety in biomedical designs. Int J Nanomedicine 2011, 6:1117-1127. 10.2147/IJN.S16603.
21. Torreela E, Kaiser M, Brun R, Mazue G, Bray MA, Pecoul B Fexinidazole- A new oral Nitronidazole drug candidate entering clinical development for the treatment of sleeping sickness. PLoSNegl Trop Dis 2010, 4(12):e923. 10.1371/journal.pntd.0000923.
22. Rodrigues ML, Nimrichter L, Cordero RJB, Casadevall A Fungal Polysaccharides: Biological Activity Beyond the Usual Structural Properties. Front Microbiol 2011, 2:e171. 10.3389/fmicb.2011.00171.
23. Umar IA, Maryoms NG, Daikwo E, Gidado A, Buratai LB, Igbokwe IO, Ibrahim MA The Effect of Aqueous Extracts of Hibiscus Sabdariffa (Sorrel) Calyces on Heamatological Profile and Organ Pathological Changes in TrypanasomaCongolense - Infected Rats. Afr J Tradit Complement Altern Med 2009, 6(4):585-591.
24. Anere JI, Fajinmi AO, Lawani FAG An analysis of humam African trypanosomiasis (HAT) in Nigeria. Science World J 2006, 1(1). e. http://www.scienceworldjournal.org/article/view/644/510.
25. Mazzio EA, Soliman KF In vitro screening for the tumoricidal properties of international medicinal herbs. Phytother Res 2009, 23(3):385-398.
26. Fouche G, Cragg GM, Pillay P, Kolesnikova N, Maharay VJ, Senabe JJ In vitro anticancer screening of South African plants. Ethnopharmacol 2008, 119(3):455-461.
27. Cai Y, Luo Q, Sun M, Corke H Antioxidant effect and phenolic compounds of the traditional Chinese medicinal plants associated with anticancer. Life science 2004, 74(17):2157-2184.
28. Romesh CH, Patter MG Antimicrobial properties, antioxidant activity and bioactive compounds from six wild edible mushrooms of western ghats of Karnataka, India. Pharmacognosy Res 2010, 2(2):107-112.
29. Getha K, Hatsu M, Wong HJ, Lee SS Submerged cultivation of Basidiomycete fungi associated with root diseases for production of valuable bioactive metabolites. J Trop Forest Sci 2009, 21:1-7.
30. Chunchao H, Guo TY A hypothesis: supplementation with mushroom-derived active compound modulates immunity and increases survival in response to Influenza virus (H1N1) infection. Evid-Based Complement Alternat Med 2011, 2011:e252501. 10.1093/ecam/neq037.
31. McDowell G, Slevin M, Krupinski J Nanotechnology for the treatment of coronary in stent restenosis: a clinical perspective. Vasc Cell 2011, 3:e8. 10.1186/2045-824X-3-8.
32. Ghanberi H, de Mel A, Seifalian AM Cardiovascular application of polyhedral oligomericsilsesquiovanenanomaterials: a glimpse into perspective horizon. Int J Nanomedicine 2011, 6:775-786.
33. Kovochich M, Marsden MD, Zack JA Activation of latent HIV using drug-loaded nanoparticles. PLoS One 2011, 6(4):e18270. 10.1371/journalpone.0018270.
34. Lejon V, Robays J, N'siesi FX, Mumba D, Hoogstoel A, Bisser S, Reiber H, Boelaert M, Buscher P Treatment failure related to intrathecal immunoglobulin M (IgM) synthesis, cerebrospinal fluid IgM, and interleukin-10 in patients with haemolymphatic stage sleeping sickness. Clin Vaccine Immunol 2007, 14(6):732-737.
35. Bisser S, N'Siesi FX, Lejon V, Preus PM, Nicuwenhove SV, Bilengue MMC, Buscher P Equivalence trial of melarsoprol and nifurtimoxmonotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness. J Infect Dis 2007, 195:322-329.
36. Ofodile LN, Uma UN, Kokubun T, Grayer RJ, Ogundipe OT, Simmonds MSJ Antimicrobial activity of some Ganoderma speciesfrom Nigeria. Pharmacol Pharmaceutical Med 2005, 19(4):310-313.
37. Jonathan GS, Awotona FE Studies on antimicrobial potentials of three Ganoderma species collected from University of Ibadan (Nigeria) botanical gardens. Afri J Biomed Res 2010, 13(2). e. http://www.ajbrui.net/ojs/index.php/ajbr/article/view/72/0.
38. Liandris E, Gazoule M, Andreadou M, Sechi LA, Rosu V, Ikonomopoulos J Detection pathogenic Mycobacteria based on functionalized quantum dots coupled with immunomagnetic separation. PLoS One 2011, 6(5):e20026. 10.1371/journal.pone.0020026.
39. Bhasker S, Tian F, Stoeger T, Kreyling W, de la Fuente JM, Grazu V, Borm P, Estrada G, Ntziachristos V, Razansky D Multifunctional nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. Part Fibre Toxicol 2010, 7:e3. PMID: 20199661. PMCID: PMC2847536.
40. Danesh-Bahreini MA, Shokri J, Samiei A, Kamali-Sarvestani EK, Barzegar-Jalali M, Mohammadi-Samani S Nanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing Leishmaniasuperoxide dismutase and evaluation of its immunogenicity in BALB/c mice. Int J Nanomedicine 2011, 6:835-842.
41. Tran PA, Webster TJ Selenium nanoparticles inhibit Staphylococcus aureus growth. Int J Nanomedicine 2011, 6:1553-1558.
42. Sokolova AY, Wyllie S, Patterson S, Oza SL, Read KD, Fairlamb AH Cross-resistance of nitro-drugs and implications for treatment of human African trypanosomiasis. Antimicrob Agents Chemother 2010, 54(7):2893-2900.
43. Likeufack ACL, Brun R, Fomena A, Truc P Comparison of the in vitro drug sensitivity of Trypanosoma brucei gambiense strains from West and Central Africa isolated in the periods 1960-1995 and 1999-2004. Acta Trop 2006, 100:11-16.
44. Wu Y, Wang D A new class of natural glycopeptides with sugar moiety-dependent activities derived from Ganoderma lucidum fruiting bodies. J Proteome Res 2009, 8(2):436-442.
45. Mazzio EA, Soliman KFA In vitro screening of tumoricidal properties of international medicinal herba. Part II. Phytother Res 2010, 24(12):1813-1824.
46. Kim MY, Seguin P, Ahn JK, Kim JJ, Chun S, Kim EH Phenolic compound concentration and antioxidant activities of edible and medicinal mushrooms from Kores. J Agric Food Chem 2008, 56:7265-7270.
47. Amori A, Vaidya JG, Deokule SS In vitro evaluation of anti-staphylococcal activity of Ganoderma lucidum, Ganoderma praelonggum and Ganoderma resinaceumfrom Pune, India. Afric J Microbiol Res 2011, 5(3):328-333.